{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:09:53Z","timestamp":1761156593189,"version":"build-2065373602"},"reference-count":45,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006264","name":"RIKEN","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006264","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["16H05387"],"award-info":[{"award-number":["16H05387"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.ijrobp.2018.11.019","type":"journal-article","created":{"date-parts":[[2018,11,17]],"date-time":"2018-11-17T17:51:37Z","timestamp":1542477097000},"page":"958-969","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Administration of Dendritic Cells and Anti-PD-1 Antibody Converts X-ray Irradiated Tumors Into Effective In situ Vaccines"],"prefix":"10.1016","volume":"103","author":[{"given":"Yuzi","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junko","family":"Zenkoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariungerel","family":"Gerelchuluun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lue","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Songjie","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaokang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Tsuboi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2018.11.019_bib1","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1056\/NEJMra1608986","article-title":"Recent developments in radiotherapy","volume":"377","author":"Citrin","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2018.11.019_bib2","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.ijrobp.2009.07.1751","article-title":"Stereotactic body radiotherapy (SBRT) for operable stage I non-small-cell lung cancer: Can SBRT be comparable to surgery?","volume":"81","author":"Onishi","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.11.019_bib3","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/S1470-2045(09)70082-8","article-title":"Systemic effects of local radiotherapy","volume":"10","author":"Formenti","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2018.11.019_bib4","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/1748-717X-9-185","article-title":"Immunological aspects of radiotherapy","volume":"9","author":"Scheithauer","year":"2014","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2018.11.019_bib5","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.canlet.2015.01.009","article-title":"Building immunity to cancer with radiation therapy","volume":"368","author":"Haikerwal","year":"2015","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ijrobp.2018.11.019_bib6","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.currproblcancer.2015.10.003","article-title":"The immune mechanisms of abscopal effect in radiation therapy","volume":"40","author":"Grass","year":"2016","journal-title":"Curr Probl Cancer"},{"key":"10.1016\/j.ijrobp.2018.11.019_bib7","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nri.2016.107","article-title":"Immunogenic cell death in cancer and infectious disease","volume":"17","author":"Galluzzi","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ijrobp.2018.11.019_bib8","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.ijrobp.2003.09.012","article-title":"Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated","volume":"58","author":"Demaria","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.11.019_bib9","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.canlet.2013.09.018","article-title":"Abscopal effects of radiation therapy: A clinical review for the radiobiologist","volume":"356","author":"Siva","year":"2015","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ijrobp.2018.11.019_bib10","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.currproblcancer.2015.10.001","article-title":"Systematic review of case reports on the abscopal effect","volume":"40","author":"Abuodeh","year":"2016","journal-title":"Curr Probl Cancer"},{"key":"10.1016\/j.ijrobp.2018.11.019_bib11","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.ctrv.2015.03.011","article-title":"The abscopal effect of local radiotherapy: Using immunotherapy to make a rare event clinically relevant","volume":"41","author":"Reynders","year":"2015","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.ijrobp.2018.11.019_bib12","doi-asserted-by":"crossref","first-page":"136","DOI":"10.21037\/tcr.2017.01.32","article-title":"The abscopal effect induced by in situ irradiated peripheral tumor cells in a murine GL261 brain tumor model","volume":"6","author":"Zenkoh","year":"2017","journal-title":"Transl Cancer Res"},{"key":"10.1016\/j.ijrobp.2018.11.019_bib13","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3892\/mco.2013.108","article-title":"Immune-maximizing (IMAX) therapy for cancer: Combination of dendritic cell vaccine and intensity-modulated radiation","volume":"1","author":"Shibamoto","year":"2013","journal-title":"Mol Clin Oncol"},{"key":"10.1016\/j.ijrobp.2018.11.019_bib14","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ejca.2016.03.067","article-title":"Can immunostimulatory agents enhance the abscopal effect of radiotherapy?","volume":"62","author":"Levy","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2018.11.019_bib15","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.ijrobp.2016.02.067","article-title":"The promise of the abscopal effect and the future of trials combining immunotherapy and radiation therapy","volume":"95","author":"Johnson","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.11.019_bib16","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ijrobp.2018.01.094","article-title":"Abscopal effects with hypofractionated schedules extending into the effector phase of the tumor-specific t-cell response","volume":"101","author":"Zhang","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.11.019_bib17","doi-asserted-by":"crossref","first-page":"36","DOI":"10.7150\/jca.5046","article-title":"Dendritic cells in the cancer microenvironment","volume":"4","author":"Ma","year":"2013","journal-title":"J Cancer"},{"key":"10.1016\/j.ijrobp.2018.11.019_bib18","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ijrobp.2018.11.019_bib19","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1158\/1078-0432.CCR-03-0380","article-title":"Intratumoral administration of dendritic cells overexpressing CCL21 generates systemic antitumor responses and confers tumor immunity","volume":"10","author":"Yang","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2018.11.019_bib20","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1158\/1078-0432.CCR-05-1986","article-title":"Systemic antitumor effect of intratumoral injection of dendritic cells in combination with local photodynamic therapy","volume":"12","author":"Saji","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2018.11.019_bib21","doi-asserted-by":"crossref","first-page":"5958","DOI":"10.1158\/0008-5472.CAN-05-0406","article-title":"Therapeutic vaccination against murine lymphoma by intratumoral injection of naive dendritic cells","volume":"65","author":"Song","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2018.11.019_bib22","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1158\/0008-5472.CAN-11-1620","article-title":"Immune inhibitory molecules LAG-3 and PD-1 synergistically regulate T-cell function to promote tumoral immune escape","volume":"72","author":"Woo","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2018.11.019_bib23","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1158\/0008-5472.CAN-14-3511","article-title":"TGF \u03b2 is a master regulator of radiation therapy-induced antitumor immunity","volume":"75","author":"Vanpouille-Box","year":"2015","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2018.11.019_bib24","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1158\/2326-6066.CIR-17-0040","article-title":"Stereotactic radiotherapy increases functionally suppressive regulatory T cells in the tumor microenvironment","volume":"5","author":"Muroyama","year":"2017","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.ijrobp.2018.11.019_bib25","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0360-3016(97)00372-6","article-title":"Effects of irradiation on the expression of major histocompatibility complex class I antigen and adhesion costimulation molecules ICAM-1 in human cervical cancer","volume":"39","author":"Santin","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.11.019_bib26","doi-asserted-by":"crossref","first-page":"610","DOI":"10.3389\/fimmu.2016.00610","article-title":"Chemoradiation increases PD-L1 expression in certain melanoma and glioblastoma cells","volume":"7","author":"Derer","year":"2016","journal-title":"Front Immunol"},{"key":"10.1016\/j.ijrobp.2018.11.019_bib27","doi-asserted-by":"crossref","first-page":"11373","DOI":"10.1038\/s41598-017-11949-9","article-title":"Alteration of PD-L1 expression and its prognostic impact after concurrent chemoradiation therapy in non-small cell lung cancer patients","volume":"7","author":"Fujimoto","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijrobp.2018.11.019_bib28","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.ijrobp.2012.06.020","article-title":"Radiation therapy to convert the tumor into an in situ vaccine","volume":"84","author":"Formenti","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.11.019_bib29","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3109\/1547691X.2014.880533","article-title":"Norm- and hypo-fractionated radiotherapy is capable of activating human dendritic cells","volume":"11","author":"Kulzer","year":"2014","journal-title":"J Immunotoxicol"},{"key":"10.1016\/j.ijrobp.2018.11.019_bib30","doi-asserted-by":"crossref","first-page":"5379","DOI":"10.1158\/1078-0432.CCR-09-0265","article-title":"Fractionated but not single dose radiotherapy induces an immune-mediated abscopal effect when combined with anti- CTLA-4 antibody","volume":"15","author":"Dewan","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2018.11.019_bib31","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13014-018-0952-y","article-title":"Modelling the immunosuppressive effect of liver SBRT by simulating the dose to circulating lymphocytes: An in-silico planning study","volume":"13","author":"Basler","year":"2018","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2018.11.019_bib32","doi-asserted-by":"crossref","first-page":"e0171559","DOI":"10.1371\/journal.pone.0171559","article-title":"A meta-analysis of the abscopal effect in preclinical models: Is the biologically effective dose a relevant physical trigger?","volume":"12","author":"Marconi","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ijrobp.2018.11.019_bib33","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/1748-717X-9-89","article-title":"Fractionated radiotherapy is the main stimulus for the induction of cell death and of Hsp70 release of p53 mutated glioblastoma cell lines","volume":"9","author":"Rubner","year":"2014","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2018.11.019_bib34","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s002620050276","article-title":"Diverse manifestations of\u00a0tumorigenicity and immunogenicity displayed by the poorly immunogenic B16-BL6 melanoma transduced with cytokine genes","volume":"42","author":"Arca","year":"1996","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.ijrobp.2018.11.019_bib35","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00262-016-1914-6","article-title":"Rationale and evidence to combine radiation therapy and immunotherapy for cancer treatment","volume":"66","author":"Ishihara","year":"2017","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.ijrobp.2018.11.019_bib36","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.ijrobp.2005.06.032","article-title":"Combining radiotherapy and immunotherapy: A revived partnership","volume":"63","author":"Demaria","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.11.019_bib37","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3389\/fimmu.2015.00505","article-title":"Radio-immunotherapy-induced immunogenic cancer cells as basis for induction of systemic anti-tumor immune responses \u2013 pre-clinical evidence and ongoing clinical applications","volume":"6","author":"Derer","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.ijrobp.2018.11.019_bib38","first-page":"8466","article-title":"Radiotherapy potentiates the therapeutic efficacy of intratumoral dendritic cell administration","volume":"63","author":"Teitz-Tennenbaum","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2018.11.019_bib39","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1158\/2326-6066.CIR-14-0196","article-title":"Stereotactic radiation therapy augments antigen-specific PD-1\u2013mediated antitumor immune responses via cross-presentation of tumor antigen","volume":"3","author":"Sharabi","year":"2015","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.ijrobp.2018.11.019_bib40","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nature14292","article-title":"Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer","volume":"520","author":"Twyman-Saint Victor","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ijrobp.2018.11.019_bib41","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1200\/JCO.2009.26.7609","article-title":"Phase I study of single-agent anti\u2013programmed Death-1 (MDX-1106) in refractory solid tumors: Safety, clinical activity, pharmacodynamics, and immunologic correlates","volume":"28","author":"Brahmer","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2018.11.019_bib42","first-page":"514","article-title":"The survival and turnover of mature and immature CD8 T cells","volume":"84","author":"McDonagh","year":"1995","journal-title":"Immunology"},{"key":"10.1016\/j.ijrobp.2018.11.019_bib43","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1200\/JCO.2017.76.2229","article-title":"Safety and clinical activity of pembrolizumab and multisite stereotactic body radiotherapy in patients with advanced solid tumors","volume":"36","author":"Luke","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2018.11.019_bib44","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.3389\/fimmu.2017.01594","article-title":"Strategies to improve the efficacy of dendritic cell-based immunotherapy for melanoma","volume":"8","author":"Hargadon","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.ijrobp.2018.11.019_bib45","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1038\/sj.bjc.6602195","article-title":"Surgery and adjuvant dendritic cell-based tumour vaccination for patients with relapsed malignant glioma, a feasibility study","volume":"91","author":"Rutkowshi","year":"2004","journal-title":"Br J Cancer"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301618340057?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301618340057?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T09:44:18Z","timestamp":1759743858000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301618340057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S0360301618340057"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2018.11.019","relation":{},"ISSN":["0360-3016"],"issn-type":[{"type":"print","value":"0360-3016"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Administration of Dendritic Cells and Anti-PD-1 Antibody Converts X-ray Irradiated Tumors Into Effective In situ Vaccines","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2018.11.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}